Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $2,724,191 |
| Sells | 24 | $2,620,999 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Aug 2024 16:01 | FATE | FATE THERAPEUTICS INC | XU YUAN | Director | 06 Aug 2024 | Sale | 633 | 4.23 | 2,678 | D |
| 05 Mar 2024 16:24 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 04 Mar 2024 | Sale | 2,447 | 7.77 | 19,013 | D |
| 30 Jan 2024 16:01 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 29 Jan 2024 | Sale | 1,849 | 5 | 9,245 | D |
| 10 Jan 2024 16:30 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 09 Jan 2024 | Sale | 10,874 | 4.37 | 47,519 | D |
| 10 Jan 2024 16:30 | FATE | FATE THERAPEUTICS INC | VALAMEHR BAHRAM | Chief R&D Officer | 09 Jan 2024 | Sale | 11,271 | 4.38 | 49,367 | D |
| 10 Jan 2024 16:29 | FATE | FATE THERAPEUTICS INC | WOLCHKO J SCOTT | President and CEO | 09 Jan 2024 | Sale | 14,391 | 4.37 | 62,889 | D |
| 10 Jan 2024 16:29 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 09 Jan 2024 | Sale | 7,028 | 4.37 | 30,712 | D |
| 03 Jan 2024 16:03 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 02 Jan 2024 | Sale | 5,182 | 3.66 | 18,966 | D |
| 28 Dec 2023 21:30 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 26 Dec 2023 | Purchase | 44,630 | 3.72 | 166,024 | I |
| 19 Dec 2023 16:01 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 18 Dec 2023 | Sale | 1,585 | 3.5 | 5,548 | D |
| 13 Nov 2023 16:01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 09 Nov 2023 | Sale | 24,363 | 2.4 | 58,471 | D |
| 21 Aug 2023 16:02 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 18 Aug 2023 | Sale | 4,718 | 2.8 | 13,210 | D |
| 07 Aug 2023 16:01 | FATE | FATE THERAPEUTICS INC | XU YUAN | Director | 04 Aug 2023 | Sale | 632 | 3.71 | 2,345 | D |
| 06 Jul 2023 17:19 | FATE | FATE THERAPEUTICS INC | POWL BRIAN T. | Chief Commercial Officer | 05 Jul 2023 | Sale | 3,854 | 4.87 | 18,769 | D |
| 06 Jul 2023 17:18 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 05 Jul 2023 | Sale | 5,182 | 4.83 | 25,029 | D |
| 15 Jun 2023 16:05 | FATE | FATE THERAPEUTICS INC | XU YUAN | Director | 14 Jun 2023 | Sale | 3,460 | 5.58 | 19,307 | D |
| 21 Apr 2023 21:55 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 21 Apr 2023 | Purchase | 256,639 | 6.18 | 1,586,029 | I |
| 21 Apr 2023 21:55 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 20 Apr 2023 | Purchase | 20,000 | 5.99 | 119,800 | I |
| 19 Apr 2023 16:07 | FATE | FATE THERAPEUTICS INC | CHU YU-WAYE | Chief Medical Officer | 18 Apr 2023 | Sale | 2,317 | 6.58 | 15,246 | D |
| 19 Apr 2023 16:07 | FATE | FATE THERAPEUTICS INC | CHU YU-WAYE | Chief Medical Officer | 18 Apr 2023 | Sale | 215 | 6.52 | 1,402 | D |
| 17 Apr 2023 21:30 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 14 Apr 2023 | Purchase | 25,700 | 6 | 154,200 | I |
| 17 Apr 2023 21:30 | FATE | FATE THERAPEUTICS INC | REDMILE GROUP, LLC | Director , 10% | 14 Apr 2023 | Sale | 302,339 | 5.84 | 1,765,660 | I |
| 13 Jan 2023 18:20 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | 13 Jan 2023 | Purchase | 36,631 | 5.43 | 198,906 | D |
| 13 Jan 2023 18:20 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | 11 Jan 2023 | Purchase | 88,048 | 5.67 | 499,232 | D |
| 11 Jan 2023 16:09 | FATE | FATE THERAPEUTICS INC | WOLCHKO J SCOTT | President and CEO | 10 Jan 2023 | Sale | 45,907 | 5.24 | 240,553 | D |
| 11 Jan 2023 16:08 | FATE | FATE THERAPEUTICS INC | VALAMEHR BAHRAM | Chief R&D Officer | 10 Jan 2023 | Sale | 10,917 | 5.24 | 57,205 | D |
| 11 Jan 2023 16:08 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | 10 Jan 2023 | Sale | 11,553 | 5.24 | 60,538 | D |
| 11 Jan 2023 16:07 | FATE | FATE THERAPEUTICS INC | PLAVSIC MARK | Chief Technical Officer | 10 Jan 2023 | Sale | 3,418 | 5.24 | 17,910 | D |
| 11 Jan 2023 16:06 | FATE | FATE THERAPEUTICS INC | DULAC EDWARD J III | Chief Financial Officer | 10 Jan 2023 | Sale | 7,331 | 5.24 | 38,414 | D |
| 11 Jan 2023 16:05 | FATE | FATE THERAPEUTICS INC | CHU YU-WAYE | Chief Medical Officer | 10 Jan 2023 | Sale | 7,825 | 5.24 | 41,003 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)